MIHAELA PENDOS: Open Payments
NPI 1740775444 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,866 in 76 payments from 10 companies in 2025. Trend: 2023 $1,611 · 2024 $1,717 · 2025 $1,866
Food & beverage: $1,859Education: $7
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $395 |
| Axsome Therapeutics, Inc. | 11 | $368 |
| E.R. Squibb & Sons, L.L.C. | 10 | $290 |
| ABBVIE INC. | 12 | $206 |
| Vanda Pharmaceuticals Inc. | 6 | $182 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $170 |
| Alkermes, Inc. | 6 | $149 |
| Supernus Pharmaceuticals, Inc. | 2 | $48 |
| Lundbeck LLC | 1 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
Products named: Auvelity, COBENFY, VRAYLAR, REXULTI, FANAPT, CAPLYTA, LYBALVI, ABILIFY MAINTENA.
Industry payments across PA — which companies pay providers there.
